Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial
- PMID: 21859489
- PMCID: PMC3170648
- DOI: 10.1186/1471-2474-12-194
Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial
Abstract
Background: Low back pain (LBP), with high incidence and prevalence rate, is one of the most common reasons to consult the health system and is responsible for a significant amount of sick leave, leading to high health and social costs. The objective of the study is to assess the cost-effectiveness and cost-utility analysis of a multidisciplinary biopsychosocial educational group intervention (MBEGI) of non-specific sub-acute LBP in comparison with the usual care in the working population recruited in primary healthcare centres.
Methods/design: The study design is a cost-effectiveness and cost-utility analysis of a MBEGI in comparison with the usual care of non-specific sub-acute LBP.Measures on effectiveness and costs of both interventions will be obtained from a cluster randomised controlled clinical trial carried out in 38 Catalan primary health care centres, enrolling 932 patients between 18 and 65 years old with a diagnosis of non-specific sub-acute LBP. Effectiveness measures are: pharmaceutical treatments, work sick leave (% and duration in days), Roland Morris disability, McGill pain intensity, Fear Avoidance Beliefs (FAB) and Golberg Questionnaires. Utility measures will be calculated from the SF-12. The analysis will be performed from a social perspective. The temporal horizon is at 3 months (change to chronic LBP) and 12 months (evaluate the outcomes at long term).Assessment of outcomes will be blinded and will follow the intention-to-treat principle.
Discussion: We hope to demonstrate the cost-effectiveness and cost-utility of MBEGI, see an improvement in the patients' quality of life, achieve a reduction in the duration of episodes and the chronicity of non-specific low back pain, and be able to report a decrease in the social costs. If the intervention is cost-effectiveness and cost-utility, it could be applied to Primary Health Care Centres.
Trial registration: ISRCTN: ISRCTN58719694.
References
-
- Humbría Mendiola A, Carmona L, Peña Sagredo JL, Ortiz AM. Grupo de Estudio EPISER. Impacto poblacional del dolor lumbar en España: resultados del estudio EPISER. Rev Esp Reumatol. 2002;29:471–478.
-
- Kovacs FM, Fernandez C, Cordero A, Muriel A, Gonzalez-Lujan L, Gil del Real MT. Non-specific low back pain in primary care in the Spanish National Health Service: a prospective study on clinical outcomes and determinants of management. BMC Health Serv Res. 2006;6:57. doi: 10.1186/1472-6963-6-57. - DOI - PMC - PubMed
-
- Gonzalez Viejo MA, Condon Huerta MJ. Disability from low back pain in Spain. Med Clin (Barc) 2000;114:491–492. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Miscellaneous
